Don Wetherhold has been appointed chief executive officer at Aprecia Pharmaceuticals. Mr. Wetherhold previously served as senior vice president, long-term care at Omnicare, Inc., and before that served as Aprecia’s corporate commercialization officer.
 
Wetherhold has 26 years of experience in the healthcare industry, including key management positions and leadership roles at Omnicare, Cardinal Health, Snyder Healthcare Sales, and Solvay Pharmaceuticals. Prior to his first tenure with Aprecia in 2010, he served as Prasco Laboratories’ senior vice president and general manager of Hampton Laine, Prasco’s branded pharmaceutical business.
 
“We are thrilled to have Don back at Aprecia, and we look forward to the leadership he will bring to this role,” said E. Thomas Arington, Aprecia’s chairman. Don was instrumental in devising our commercialization strategy at Aprecia. We are now preparing to file our first product, and we have two additional products in development. The company is poised for commercial success, and Don’s expertise and commitment certainly augment Aprecia’s momentum. We also know that Don’s extensive experience within the healthcare field will serve both him and the company well. Furthermore, we highly value not only his experience and intelligence but also his character.”